In addition to androgenic properties mediated via androgen receptors, dihydrotestosterone (DHT) also regulates estrogenic functions via an alternate pathway. These estrogenic functions of DHT are mediated by its metabolite 5␣-androstane-3␤, 17␤-diol (3␤-diol) binding to estrogen receptor ␤ (ER␤). CYP7B1 enzyme converts 3␤-diol to inactive 6␣-or 7␣-triols, and plays an important role as a regulator of estrogenic functions mediated by 3␤-diol. Using a mutant mouse carrying a null mutation for the CYP7B1 gene (CYP7B1KO), we examined the contribution of CYP7B1 on physiology and behavior. Male, gonadectomized CYP7B1KO and their wild type (WT) littermates were assessed for their behavioral phenotype, anxiety-related behavioral measures and hypothalamic pituitary adrenal (HPA) axis reactivity. No significant effects of genotype were evident in anxietylike behaviors in open field (OFA), light-dark (L/D) exploration, and elevated plus maze (EPM). Testosterone (T) significantly reduced open arm time on the EPM, while not affecting L/D exploratory and OFA behaviors in CYP7B1KO and WT littermates. T also attenuated the corticosterone response to EPM in both genotypes. In gonadectomized animals, T was able to reinstate malespecific reproductive behaviors (latencies and number of mounts, intromission, and ejaculations) in the WT, but not in the CYP7B1KO mice. The male reproductive behavior defect in CYP7B1KO appears to be due to their inability to distinguish olfactory cues from a behavioral estrous female. CYP7B1KO mice also showed a reduction in androgen receptor (AR) mRNA expression in the olfactory bulb. Our findings suggest a novel role for the CYP7B1 enzyme in the regulation of male reproductive behaviors. T estosterone (T) and its metabolites play an essential role in organization of the brain during development and facilitating activational effects during adulthood (1-5). It is well recognized that these effects are mediated in part by 17-␤ estradiol (E 2 ) and 5␣-dihydrotestosterone (DHT), the two biologically active metabolites of T. In the central and peripheral nervous tissues of many mammals, T is intracellularly converted to E 2 by the aromatase enzyme (6) or to DHT by the enzyme 5␣ reductase (7). Following aromatization, E 2 binds to two known estrogen receptor (ER) subtypes, ER␣ or ER␤ (8 -10), while DHT binds to androgen receptors (AR) with higher affinity than T (11).
T estosterone (T) and its metabolites play an essential role in organization of the brain during development and facilitating activational effects during adulthood (1) (2) (3) (4) (5) . It is well recognized that these effects are mediated in part by 17-␤ estradiol (E 2 ) and 5␣-dihydrotestosterone (DHT), the two biologically active metabolites of T. In the central and peripheral nervous tissues of many mammals, T is intracellularly converted to E 2 by the aromatase enzyme (6) or to DHT by the enzyme 5␣ reductase (7) . Following aromatization, E 2 binds to two known estrogen receptor (ER) subtypes, ER␣ or ER␤ (8 -10) , while DHT binds to androgen receptors (AR) with higher affinity than T (11) . DHT, the nonaromatizable androgenic metabolite of T, selectively activates ARs (12) . Recent reports indicate that while DHT does not undergo aromatization, it is further metabolized to either 5␣-androstane-3␣, 17␤ -diol (3␣-diol) by the enzyme 3␣ hydroxysteroid (3␣-HSD), or to 5␣-androstane-3␤, 17␤ -diol (3␤-diol) by the enzymes 3␣-HSD, 3␤ hydroxysteroid (3␤-HSD), or 17␤-hydroxysteroid dehydrogenase (13) (14) (15) (16) (17) (18) . Furthermore, 3␣-diol, but not 3␤-diol, serves as a potentially important source of DHT, since the bioconversion of DHT to 3␣-diol is reversible (70%) (19) . Conversely, DHT to 3␤-diol conversion is unidirectional, with 3␤-diol metabolizing to inactive 6␣-or 7␣-triols (5␣-androstan-3␤, 6␣, 17␤-triol; 5␣-androstan-3␤, 7␣, 17␤-triol) by the actions of cytochrome P450 -7B1 (CYP7B1) enzyme, which catalyzes the 7␣-hydroxylation of 3␤-diol (15, 20) . All the steroid-metabolizing enzymes involved in 3␤-diol syntheses have been identified in the brains of rats and mice (21, 22) .
Although the metabolites 3␣-diol and 3␤-diol have low binding affinity to AR, they have been reported to mediate biological responses via activation of other receptors. 3␣-diol, but not 3␤-diol, has been demonstrated to exert various behavioral effects by modulating GABA A receptors (23, 24) . While 3␣-diol has lower affinity for both ER subtypes (25) (26) (27) , 3␤-diol has been shown to bind both ER␣ and ER␤ (26) , preferentially binding ER␤ to activate transcriptional processes in vitro (27) (28) (29) (30) . Using AR and ER antagonists Lund et al (31) (32) (33) demonstrated that ER␤ activation by 3␤-diol decreased anxiety-like behaviors and activation of the hypothalamic pituitary adrenal (HPA) axis in adult male rats, suggesting that 3␤-diol can mediate estrogenic functions of T or DHT by binding to ER␤. Agonism of ER␤ by high levels of 5␣-reduced androgen metabolites during the neonatal period is also thought to influence affective and reproductive behaviors in adult males (34, 35) . Prenatal exposure of male rats to ER␤ agonist not only increased anxiety and aggression during adulthood (35) but also suppressed male reproductive performance and their ability to attract a mate (50) . Furthermore, administration of 3␤-diol elicited a limited display of male reproductive behavior in castrated rats compared to those treated with T, suggesting that 3␤-diol can mediate estrogenic functions (36) , perhaps by activation of ER␤.
The enzyme CYP7B1 belongs to the family of cytochrome P450 enzymes, which catalyze oxidative conversion of steroids, lipids and xenobiotics. It is predominantly expressed in the brain, with lower expression in the spleen, heart, kidney, liver, prostate, ovary, uterus and mammary gland (33, 37) . In addition to its role in the hydroxylation of 3␤-diol, it participates in cholesterol homeostasis (38) , ER-mediated cardio-protective effects in vasculature (39) and immunoglobulin production (40) . Loss of CYP7B1 in mutant female mice (CYP7B1KO) leads to estrogenization of the uterus and mammary tissues, early onset of puberty and early ovarian failure (41) . CYP7B1KO male mice have smaller prostates, which are hypoproliferative prior to puberty (15) . These changes have been ascribed to excess 3␤-diol, postulated to have accumulated in the absence of CYP7B1, leading to the activation of the ER␤ (15, 41) . To our knowledge, the contribution of CYP7B1 on stress responsiveness, anxiety and reproductive behaviors in male mice has not been examined. We hypothesized that loss of CYP7B1 would impair HPA axis response to stress, anxiety-like behaviors and reproductive behavior in male mice. We demonstrate that in the male mice, CYP7B1 is essential for the display of male reproductive behavior, and their ability to distinguish pheromonal cues of behavioral estrous female, but not in their stress responsiveness and anxiety-like behaviors.
Materials and Methods

Animals
Heterozygous male and female CYP7B1 mice, isogenic on C57BL/6J background, were obtained from Dr. David Mangelsdorf (University of Texas Southwestern), and a breeding colony established at Baylor College of Medicine. The animals were genotyped using PCR analyses of tail DNA (38) . All littermates were housed two to five per cage, under a 12-hour light and 12-hour dark light cycle (lights on at 0600 hours and off at 1800 hours), with ad libitum access to a phytoestrogen-free food (modified AIN-93G, DYET # 101 591 with corn oil substituted for soy oil; Dyets, Inc, Allentown, PA) and water. Animals used for reproductive behavior tests were housed under reverse light cycle conditions (1200 hours-light and 1200 hours-dark) with lights off at 0600 hours. Behavior assessment was done between 0900 hours and 1500 hours. All animal protocols were approved by the Institutional Animal Care and Use Committee of Baylor College of Medicine and were conducted in accordance with the National Institutes of Health Guidelines.
Neurological Screen
Neurological screen (42) adapted from the Irwin Screen (43) was used to identify gross phenotypical abnormalities between wild (WT) and CYP7B1KO littermates. Each intact animal was individually observed in a clean cage for the duration of one minute and the parameters scored as described in our previous publication (44) .
Hormone Treatments and Behavioral Assays
Male mice (n ϭ 123) were gonadectomized (GDX) at 8 weeks of age under isoflurane anesthesia, and implanted with 3 mm testosterone (T) or blank pellets (Innovative research of America, Sarasota, FL), subcutaneously, in the nape of the neck, to provide a constant hormone source. On week 10, the animals were divided into 2 groups and subjected to behavioral tests. Animals in group I (n ϭ 33; 7-10 per treatment group) were subjected to a behavioral test battery consisting of open field activity (OFA), light/dark box (L/D) and rotarod, one behavioral test per week, from least invasive to most invasive as previously described (44) .
Motor coordination and balance were tested using an accelerating rotarod (UGO Basile Accelerating Rotarod, Milan) following the procedures of McIlwain et al (45) . The second group of animals (n ϭ 90; 22-24 per treatment group) was assessed for their male reproductive behaviors (week 10 -15) and olfactory cue recognition (week 16). Following olfactory assessment, group II animals were split into 2 subgroups; IIA (n ϭ 46) and IIB (n ϭ 44). Two of the animals in subgroup IIA were removed from further study since they developed ulcerative dermatitis. The animals in subgroup IIA (n ϭ 44; 11 per treatment group) were examined for their behaviors (week 17) in marble burying and on the elevated plus maze (EPM). Following EPM, the animals were killed, trunk blood collected for Corticosterone (CORT) assays and brains frozen for studies beyond the scope of this project. Animals in subgroup IIB (n ϭ 44; 11 per treatment group) were killed (week 17), trunk blood collected for plasma T measurements and brains frozen for qRT-PCR analyses (n ϭ 4 -8 per treatment group).
Plasma Hormone Measurements
Baseline plasma CORT measurements were measured in10-week old, age-matched intact male WT and CYP7B1KO mice taken from their home cage. Plasma CORT levels were measured in 10-week old, T or blank pellet-implanted GDX animals, taken directly from their home cage (prestress) or following EPM (poststress). Trunk blood was collected into chilled microtainers containing 0.5M EDTA and 4 g/ml Aprotinin, centrifuged at 4°C, plasma collected and preserved at -80°until assayed for CORT using radioimmunoassay (RIA) (44) . Total and free plasma T levels were measured using an ELISA kit (Alpha Diagnostics Inc, San Antonio, TX) following the manufacturer's directions. The minimum detectable dose was 0.02 ng/ml and the intra-assay coefficient of variation for both of the assays was 0.11.
Male Reproductive Behavior
Male-typical reproductive behaviors of gonadectomized WT and CYP7B1KO mice were examined in the presence of sexually receptive stimulus females. Stimulus females consisted of agematched, ovariectomized WT littermates, which were primed by subcutaneous injections of estradiol benzoate (EB; 0.5 g), followed 48 hours later by progesterone (P; 100 g). Testing was performed under red light during the dark phase of the reverse light cycle, 6 hours after progesterone administration. The males were exposed to stimulus females for 4 consecutive weeks (once per week; weeks 10 -13) prior to scoring for male reproductive behavior performance on weeks 5 and 6 (weeks 14 -15) per established protocols (46) .
A female mouse was introduced into the home cage (27 ϫ 16.5 ϫ 12.5 cm) of a single-housed male. A mirror stand (mirror inclined at an angle of 45°) was used to allow for ventral viewing. Once the female was introduced, males were allowed 1800 seconds to either ejaculate or intromit. Once ejaculation occurred the test was terminated. If the male neither intromitted nor ejaculated within1800 sec, he was considered sexually inactive and given the maximum score for latency of 1800 seconds. Ejaculations were confirmed by checking for vaginal plugs in the females immediately after the testing session. Recorded measures included the total number of mounts, intromissions, and ejaculations, as well as their latencies. The observers were blind to the treatment and genotype.
Olfactory Capacity Test
To evaluate the olfactory capacity, each mouse was allowed to discover a randomly hidden piece of Oreo © cookie (5 mm 3 ) placed under the clean, fresh bedding in an arena (26 ϫ 15 x 12 cm). The latency to discover the cookie was recorded. If discovery time exceeded 5 minutes, the test was terminated.
Olfactory Preference Test
A male mouse's olfactory preference for soiled bedding from a male, behavioral estrous female, or clean bedding placed in three bowls (7.5 ϫ 7.5 ϫ 2.5 cm), 17 cm apart, in a 42 ϫ 20 x 20 cm chamber was examined. The time spent by each mouse investigating each bowl was recorded for a total of 10 minutes. Soiled bedding from 10 cages of gonad-intact WT male mice, housed four per cage was collected over 24h. Bedding from females in behavioral estrous was collected from 10 cages of ovariectomized WT female mice that were primed with 0.5 g EB (48 hours) and 100 g P (6 hours). Clean bedding comprised of fresh bedding (Harlan Teklad).
Brain Microdissection, RNA Isolation, and RealTime Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR)
Olfactory bulbs were removed from the frozen brains (n ϭ 32) and the remaining tissue was sectioned at a thickness of 300 m using a Leica CM3050S cryostat (Leica, Buffalo Grove, IL). The hippocampus, cerebellum, medial amygdala and medial basal hypothalamus regions were identified using a brain atlas (47) , and the areas punched bilaterally using the Palkovits punch technique. Total RNA was extracted from the micropunches following the procedure of Ribaudo et al (48) . Purity and concentration of RNA was confirmed spectrophotometrically using Nanodrop 2000 (Thermo Scientific, Wilmington, DE). One microgram of total RNA per sample was reverse-transcribed using the iScript cDNA synthesis kit (BioRad, Hercules, CA). The resulting cDNA was quantified using a fluorescence detection reagent (Molecular Probes, Eugene, OR). The quantity of cDNA in each PCR reaction was normalized based on the fluorescence quantification, and qRT-PCR was performed using a Roche LightCycler 480 employing SYBR green detection chemistry. The initial template for each gene was quantified by comparison to a standard curve generated with product formed by primers for AR [accession: NM013476.3 (sense: 5Ј-AGCGCAATGCCGCTATGGGG -3Ј); (antisense: 5Ј TGAGGGGGCCGAGTGTAGCC -3Ј)] or CYP7B1, aromatase, 17␤-HSD, and ER␤ (sequences described in our earlier publication (32) . The qRT-PCR conditions were 95°C for 3 minutes, followed by 50 cycles of 95°C for 15 seconds and 60°C for 1 minute. After the last PCR cycle, each sample was subjected to a thermal melting curve analysis according to the Roche LightCycler 480 software protocol (Roche, Indianapolis, IN). For each RNA sample, a no-reverse transcriptase reaction was run in parallel to cDNA synthesis, and measured by qRT-PCR to control for genomic DNA contamination. Each qRT-PCR reaction was verified for a single PCR product of expected size, using thermal melt curve disassociation. PCR products of the primers were checked for correct size using 2% agarose gel electrophoresis. Absolute quantification procedure was used for qRT-PCR assay and transcript abundance was expressed as molecules of AR mRNA (49) . All samples were assayed in duplicate and the variation between the duplicates was less than 10% in all cases. mRNA for AR, ER␤, CYP7B1, aromatase and 17␤-HSD was quantified from tissues from 4 -8 frozen brains (per treatment group).
Calbindin Immunohistochemistry and Microscopy
Anesthetized, intact male and female CYP7B1KO and WT mice (10 week old) were intracardially perfused with 4% paraformaldehyde in 0.1M PBS (pH 7.4). The fixed brains were removed from the cranial cavity, left overnight in 4% paraformaldehyde, transferred to a 30% sucrose solution until saturated and frozen in OCT for sectioning.
Frozen mouse brains were sectioned coronally at 35 m using a cryostat. Immunohistochemistry was performed on free-floating sections as previously described (50) using primary antiserum for Calbindin D28k (Millipore, Billerica, MA), at 1:20,000 dilution (4% NGS and TBS-TX). Following incubation for 1 hour in biotinylated goat-anti rabbit antibody in TBS-TX (1:1000; Vector Laboratories, Burlingame, CA), TBS rinses and 1 hour incubation in avidin-biotin complex (ABC) (ABC Elite kit, Vector Laboratories, Burlingame, CA), the tissue was developed for visualization of Calbindin positive cells using diaminobenzidine as the chromagen. Sections were rinsed in TBS, mounted on gelatin-coated slides, and coverslipped with Permount. Analysis of Calbindin positive cells was done using a Zeiss Axioskop microscope equipped with Neurolucida v.7 software (MicroBrightField Inc, Williston, VT). Sections were examined and Calbindin-immunoreactive cells were quantified in the POA within a 250 ϫ 250 m square grid region (51, 52) .
Statistical Analysis
Data are presented as mean Ϯ SEM and were analyzed by the methods as appropriate: t test, one-way or two-way ANOVA using the Prism statistical program (GraphPad Software, San Diego, CA). P values of Ͻ 0.05 were considered statistically significant. Statistically significant two-way ANOVAs were followed by the post hoc Tukey/Kramer test for multiple comparisons.
Results
CYP7B1KO Mice Exhibit Normal Gross Phenotype
Intact CYP7B1KO mice were viable, and exhibited no abnormal gross physical appearance. There were no visible signs of barbering (characteristic areas of whisker and fur loss), poorly groomed fur, exophthalmos, palpebral closure, and piloerection in the CYP7B1KO or their WT littermates. Spontaneous behaviors like wild-running, circling, jumping, freezing, excessive grooming, or hunched body posture while walking were not evident in either the CYP7B1KOs or their WT littermates. There were no significant differences in ear twitch, eye blink, or whiskertouch reflexes between the genotypes.
Testosterone Replacement Levels were Similar in WT and CYP7B1KO Mice
Two-way ANOVA (genotype x T treatment) analysis of total and free T plasma levels measured in gonadectomized CYP7B1KO and their WT littermates ( Figure 1A -B), revealed a significant effect of T treatment on both free T [F (1, 23) ϭ40.75; P Ͻ .0001] and total T [F (1, 25) ϭ 208.6; P Ͻ .0001] levels in WT and CYP7B1KOs. No significant effect of genotype was observed in total and free T levels in WT and CYP7B1KOs. Post hoc analysis confirmed that both free and total T levels were significantly increased in T-treated WT and CYP7B1KO mice compared to blank controls (P Ͻ .0001). No significant difference was noted in total and free T levels between the T-treated WT and CYP7B1KO mice (Figure 1 A-B) .
CYP7B1 is not Involved in the Regulation of Anxiety-Related Behaviors
Two-way ANOVA (genotype x T treatment) revealed no significant genotype or T treatment effects on motor coordination, balance, or locomotion, as indicated by the mean time spent on the rotarod and total distance traveled in the OFA (Table 1) .
Analysis of data (two-way ANOVA) from animals implanted with blank pellets, subjected to OFA, L/D exploration showed no significant effect of genotype or T treatment (Table 1) . While there was a significant effect of T treatment on open arm exploration on the EPM [F (1, 39) ϭ 6.948; P ϭ .0120], no genotype or interaction effects were present. Post hoc analysis showed no significant effects in the open arm exploration. T-treatment of WT and CYP7B1KO mice decreased anxiety-like behaviors on the EPM, compared to those of blank controls.
CYP7B1 Enzyme has no Effect on Marble Burying Behaviors
Both CYP7B1KO and WT mice, implanted with blank pellets, demonstrated no difference in the marble burying behaviors (Table 1) . A significant effect of T treatment [F (1, 40) ϭ 16.86; P ϭ .0002] was revealed by two-way ANOVA analysis (T treatment x genotype) where T significantly enhanced marble burying behavior in WT and CYP7B1KO mice. Post hoc analysis revealed that T significantly increased the number of marbles buried by both WT and CYP7B1KO mice (P Ͻ .05).
HPA Axis Reactivity is not Impaired in CYP7B1KO Mice
Unpaired t test showed no genotype differences in the basal levels of CORT in intact mice (Figure 2A) . Two-way Figure 1 . Total and free circulating Testosterone in Testosterone-and blank-pellet implanted wild type (WT) and CYP7B1 knockout (CYP7B1KO) mice. 8-week old wild type (WT) and CYP7B1KO mice were gonadectomized and subcutaneously implanted with blank or Testosterone-pellets. On week 10 they were euthanized and blood levels of free and total Testosterone measured. 2-way ANOVA revealed a significant effect of T treatment on the levels of (A) Total Testosterone and (B) Free testosterone in both genotypes compared to those implanted with blank pellets (*P Ͻ .0001). Data are expressed as mean Ϯ sem; n ϭ 11 per group. ND ϭ Nondetectable.
ANOVA analyses of prestress CORT levels in GDX mice demonstrated no significant differences between the genotypes and the administered treatments ( Figure 2B ). Poststress CORT levels following EPM (a processive stressor; Figure 2C ), analyzed by two-way ANOVA (T treatment x genotype) showed a significant effect of T treatment [F (1, 40) ϭ 48.98; P Ͻ .0001]. No genotype or interaction effects were present. Together, the data suggest that although T treatment consistently inhibited HPA activation following a stressor, deletion of the CYP7B1 gene had no effect on baseline HPA axis activity or reactivity to a processive stressor.
CYP7B1KO Mice Demonstrate Impaired Male Reproductive Behavior
T treatment significantly increased the number of mounts and intromissions in gonadectomized CYP7B1KO and WT control mice ( Figure 3A-B) . Furthermore, CYP7B1KO mice showed prolonged mount and intromission latencies within the testing period ( Figure  3C-D) . T treated CYP7B1KO mice that showed intromission with longer lasting thrusts, along with the characteristic behavioral ejaculations, often did not deposit visible vaginal plugs in the stimulus female mice (only 2 of 21 females examined showed plugs). CYP7B1KO mice displayed reflexive erections after manual retraction of penile sheath comparable to the WT littermates.
Two-way ANOVA showed a significant effect of T treatment on the following measurements: (1) Post hoc analysis showed that T treatment had a significant effect on the number of mounts (P Ͻ .0001) in both the WT mice (P Ͻ .0001) and CYP7B1KO mice (P Ͻ .05) compared to their blank-implanted littermates. Ttreatment had a significant effect on the number of intromissions in the WT mice (P Ͻ .0001), and not in the CYP7B1KO mice (P Ͼ .05) compared to their blank-implanted littermates. Intromission latency, but not the mount latency was significantly reduced by T-treatment in the WT mice (P Ͻ .0001) and CYP7B1KO mice (P Ͻ .05) compared to their blank-treated littermates. Furthermore, post hoc analyses showed a significant effect of genotype on the number of mounts, (P Ͻ .0001) intromissions (P Ͻ .001), and intromission latencies (P Ͻ .001) in the T treated WT mice compared to T-treated CYP7B1KO littermates.
CYP7B1KO Mice have decreased Olfactory Preference for Female Bedding
WT and CYP7B1KO mice with blank implants, exposed to clean, soiled male, or behavioral estrous female bedding, demonstrated no preference for any type of bed- CYP7B1 is not involved in the regulation of anxiety-like behaviors. The elevated plus maze, light/dark box and open field chamber were used to assess anxiety-like behavior, as measured by time spent and/or entries in the exposed sections of each apparatus. 8-week old wild type (WT) and CYP7B1 knockout (CYP7B1KO) mice were gonadectomized and subcutaneously implanted with blank or Testosterone-pellets. The animals were subjected to behavioral test battery beginning on week 10 as described in materials and methods. Testosterone (T)-implanted WT and CYP7B1KO mice showed statistically higher open time ratios than their blank (B)-implanted counterparts (*P Ͻ 0.01). The marble-burying task was used to assess defensive burying behavior as dictated by number of marbles buried. Testosterone significantly increased the number of marbles buried in both WT and CYP7B1KO mice (*P Ͻ 0.05). No significant genotype or treatment differences were observed in learning and locomotor activity assessed on the rotarod apparatus. n ϭ 7-11 per treatment group. 
Olfactory Capacity is Not Impaired in CYP7B1KO Mice
General odor recognition is not impaired in CYP7B1KO mice. The latency to identify the hidden palatable object was not significantly different between the mice of both genotypes in the presence or absence of T treatment ( Figure 4D ).
CYP7B1KO Mice have Lower Levels of AR and ER␤ mRNA in the olfactory bulb
AR mRNA levels extracted from olfactory bulb, and micropunches of medial amygdala or the POA, using qRT-PCR are represented in Figure 5 A. Two-way ANOVA showed a significant effect of T treatment [F (1, 27) ϭ 8.055; P ϭ .0085) and genotype [F (1, 27) ϭ11.38; P ϭ .0023] on AR mRNA expression levels in the olfactory bulb. No interaction effect (T treatment x genotype) was observed on AR mRNA expression in the olfactory bulb. Testosterone treatment reduced AR mRNA levels in the olfactory bulb of both CYP7B1KO and WT mice ( Figure 5A ). No genotype or T treatment effects were observed in AR mRNA levels (Femtograms of template) in the medial amygdala [MeA (WT-blank 1.0e-05, Ϯ 0.1e-05; WT-T treatment 1.0e-05, Ϯ 0.2e-05; CYP7B1KO-Blank 1.2e-05, Ϯ 1.5e-05, CYP7B1KO-T treatment 0.7e-05, Ϯ 0.3e-05) or preoptic area (POA; WT-blank 3.0e-.5, Ϯ 0.6e-05; WT-T treatment 1.8e-05, Ϯ 0.6e-05; CYP7B1KO-Blank 2.7e-05, Ϯ 0.8e-05; CYP7B1KO-T treatment 3.0e-05, Ϯ 0.6e-05), and in other areas examined (data not shown), suggesting a region-specific role for the CYP7B1 enzyme in the modulation of AR transcripts.
Two-way ANOVA of ER␤ mRNA levels measured using qRT-PCR indicated significant effect of genotype [F (1, 12) ϭ 4.838; P ϭ .0482], but not T treatment or interaction effects. Post hoc comparison showed no significant genotype or treatment effects in the olfactory bulb ( Figure 5B ). We also confirmed that CYP7B1 mRNA levels (Femtograms of template) were significantly lower (P ϭ .015) in the CYP7B1KO mice (0.08 e-05 Ϯ 0.06 e-05) compared to those in their WT littermates (0.84 e-05 Ϯ 0.25 e-05). No significant genotype or treatment effects were observed in aromatase and 17␤ HSD mRNA levels in all the regions examined (data not shown).
Intact Neuronal Differentiation of the POA of CYP7B1 Mice
Quantitative analysis of Calbindin D28K-immunoreactivity (Calb-ir), a morphological biomarker for sexually dimorphic nucleus of the POA (51) examined in the coronal brain sections of the WT and CYP7B1KOs, showed no significant difference in the POA of CYP7B1KO mice compared to their WT littermates in both the sexes ( Figure  5E ). A main effect of sex [F (1, 22) ϭ 7.027; P ϭ .015] was observed, with a greater number of Calb-ir cells in the POA in males than in females. No obvious qualitative differences in Calb-ir were observed in the other brain regions examined.
Discussion
In the present study, we used a comprehensive battery of behavioral tests in combination with molecular approaches to study the functional role of CYP7B1 in the regulation of HPA axis response to stress, anxiety-like behaviors and male reproductive behaviors. Our results demonstrate that CYP7B1 has a functional role in the modulation of male reproductive behaviors, but not in stress hormone reactivity or anxiety-like behaviors.
A large number of studies have demonstrated that T and its metabolites play a key role in the control of male typical reproductive behaviors (1) (2) (3) (4) (5) (6) (7) (8) . In the present study, we questioned whether the loss of CYP7B1 might impact male copulatory behaviors in gonadectomized WT and CYP7B1KO mice. Castration of the adult male WT and CYP7B1KO mice resulted in a decrease in intromission and ejaculation behaviors in both genotypes. Interestingly, T replacement increased the number of mounts and intromissions in WT mice, but not in the CYP7B1KO mice. In addition, T treatment elicited shorter intromission and mounting latencies in the WT mice, confirming the effectiveness of T in regulation of male sexual behavior (53) . While T treatment of CYP7B1KO mice significantly reduced their mounting and intromission latencies, less than10% of them deposited visible copulatory plugs, suggesting that prostate gland abnormality could have compromised the coagulation of the ejaculate (15, 54) . It seems unlikely that the inability of CYP7B1KO to display male-typical mating behaviors could be attributed to circulating T, since circulating T levels were comparable between the genotypes. One interpretation could be that the reduction in ARs observed in the CYP7B1 adversely affected their reproductive behavior. ARs expressed in the olfactory bulb have been shown to be crucial for the discrimination of neural responses to olfactory cues that signal the presence of potential mates (55) . Mice deficient in ARs, ie, testicular feminization mutation (Tfm), AR knockouts, and those with a single copy mutation of the AR gene (X Tfm Y), are not responsive to androgens and exhibit impaired (55, 56) . An alternative explanation is that deletion of CYP7B1 during critical period of development leads to excess perinatal 3␤-diol exposure, creating an estrogenic environment (41) , which in turn influences the development of neural circuits via ER␤. Alteration in the normal estrogen levels during critical developmental stages has been shown to impair male reproductive behaviors during adulthood through their actions on ER␤ (34, 57, 58) . Furthermore, neonatal administration of ER␤ agonist, but not ER␣ nor EB, has been shown to increase anxiety and aggression in male rats during adulthood (35) . These observations suggest that neonatal exposure to high levels of testicular androgen metabolites with agonistic activity on ER␤ agonists could modulate neuroendocrine pathways and influence behaviors during adulthood. In rodents, steroid hormonedriven olfactory cues play a critical role in regulating reproductive behaviors. Our data suggest that the ability to recognize hidden palatable objects was not hampered in both the CYP7B1KO and their WT littermates. However, unlike WT mice which respond to olfactory cues of potential mates and exhibit exploratory behaviors (59), CYP7B1KO male mice showed decreased preference for urinary odors present in soiled bedding from behavioral estrous females, suggesting a specific deficiency in pheromonal cue recognition. Studies in rats, mice and hamsters indicate that olfactory inputs are essential for male sexual arousal and mating performance, since olfactory bulb removal eliminates sexual behavior in the males (60) . AR knockouts neither exhibited partner preference, nor spent time sniffing behavioral estrous female bedding in a three-choice test, suggesting that ARs are required for the detection and processing of behavioral responses to pheromonal cues from conspecifics (55, 61) . Since the accessory olfactory bulb (AOB) located on the dorso-posterior surface of the main olfactory bulb (MOB) plays an important role in conspecific recognition in most vertebrate species, it is conceivable that a reduction in functional AR in the olfactory bulb of CYP7B1KO could account for the impaired processing of pheromonal cues in these mice. Since androgenic and estrogenic signaling are crucial for consummatory features of male sexual behaviors, disruption . CYP7B1KO mice show impaired olfactory preference to odors. Gonadectomized, testosterone-or blank-pellet implanted WT and CYP7B1KO mice were exposed to clean, behavioral estrous female, and male bedding in a chamber as described in Materials and Methods. WT and CYP7B1KO mice implanted with Testosterone pellets showed no preference for clean bedding (A) and male bedding (C), as measured by time spent investigating the bedding. B, Testosterone pellet implanted WT, but not CYP7B1KO mice, showed preference for the soiled bedding from behavioral estrous female. Neither WT nor CYP7B1KO mice implanted with blank pellets showed any preference for any of the bedding type. D, No genotype or T treatment effects were seen in the animals' ability to find a hidden palatable object. (*P Ͻ .0005). Data are expressed as mean Ϯ sem; n ϭ 11 per treatment group. Figure 5 . Quantitative RT-PCR measurement of mRNA levels in micropunches from olfactory bulb of male CYP7B1KO mice. Absolute levels of mRNA levels were determined by comparison to a standard curve of known amounts of the mRNA of interest. AR mRNA levels were significantly reduced in the total RNA from olfactory bulb (A) of CYP7B1KO mice compared to their WT littermates (*P Ͻ .05). Significant differences were seen in ER␤ mRNA in the olfactory bulb between the genotypes (B). AR ϭ androgen receptor, ER␤ ϭ estrogen receptor beta. Each panel shows levels of mRNA in wild type (WT) and CYP7B1 knockout mice (CYP7B1KO) that were treated with vehicle or testosterone for two-weeks prior to euthanasia. Data are expressed as mean Ϯ sem, n ϭ 4 -8 per treatment group.
in the processing and transmission of this signaling may result in the impairment of reproductive behaviors. Interestingly, we did not detect differences in the AR expression in the medial POA, the main integratory nucleus of male sexual behaviors (62, 63) , suggesting that CYP7B1 deletion disrupts the processing of sexually relevant pheromonal cues in a tissue specific manner.
It is possible that the decreased levels of AR mRNA expression in the olfactory bulb could be due to accumulation of 3␤-diol in CYP7B1KO mice, which binds to both ER␣ and ER␤ (with a higher affinity for the latter) (41) . 3␤-diol causes in a significant decrease in AR levels in the ventral prostate of WT, but not mice deficient in ER␤, suggesting that ER␤ -3␤-diol complex could be involved in the regulation of AR expression (64) . Ovarian follicular atresia due to a loss of AR regulation in ovarian follicles was observed in the absence of ER␤ in female mice (65) . In addition, Omato et al (2005) demonstrated a complete loss of AR in the uterus of CYP7B1KO female mice upon treatment with 3␤-diol, leading to estrogenization of the uterus (41) . Since CYP7B1-mediated pathway is responsible for the termination of estrogenic actions of 3␤-diol, a metabolite of T, it could possibly regulate the balance between ER and AR signaling. Although CYP7B1 deletion resulted in reduced expression of AR and ER␤ mRNA levels in our current studies, the mRNA expression levels of aromatase and 17␤ HSD in hypothalamus remained unaffected, suggesting that the effects of this enzyme deletion could be pathway specific.
The organizational effects of steroid hormones play an important role in mediating sex differences in the brain during development. The POA becomes sexually dimorphic under the control of estrogenic metabolites of T. The calcium binding protein, Calbindin 28 kDa, has been used as a molecular biomarker for identification of morphological sex differences in the mouse brain (51, 52, 66) . To determine whether abrogation of CYP7B1 could have disrupted the sexual differentiation of the brain, and hence male reproductive behaviors, we examined Calbindin-immunoreactive neurons in the POA of male and female mice. Consistent with published reports (67) , the POA in the male brains had a higher number of Calbindin-immunoreactive cells compared to the females. No genotypic differences were noted in the Calbindin-immunoreactive cell numbers in the POA. Although our results suggest that the deletion of CYP7B1 had no effect on the sex difference in the POA in mice, we cannot exclude the possibility that the deletion could have affected the sexually dimorphic vomeronasal system as it has been reported in rats (68) . Further studies will examine the effects of CYP7B1 deletion on the vomeronasal system in greater detail.
Androgens and estrogens, acting through their cognate receptors, play an important role in the regulation of sexspecific differences in the activation of the HPA axis. It is well known that estrogens enhance, while androgens inhibit HPA axis reactivity to stress (31, 69 -73) . Furthermore, recent studies indicate that in addition to T and DHT, 3␤-diol, can inhibit HPA axis reactivity by binding to ER␤ (31, 32, 74) , similar to ER␤ agonist, diarylpropionitrile (DPN). Together, these data suggest that T regulation of HPA axis reactivity to stress can be mediated by the activation of ER␤ by 3␤-diol, whose in vivo efficacy is tightly regulated by enzyme CYP7B1 (15) .
An alternative possibility for the effects of CYP7B1KO on reproductive behaviors could be due to alternative metabolic functions of CYP7B1. CYP7B1 has been shown to be involved in the hydroxylation of dehydroepiandrosterone (DHEA) to 7 hydroxy DHEA (75), the inhibition of which could result in elevated levels of T precursors, androstenedione or androstenediol, other metabolites of DHEA. However, the direction of the effects that we see (reduced androgen dependent behaviors) seems to rule out modifications of this pathway. Although DHEA is an adrenal gland-derived androgen prohormone in human and hamster, it is not produced by the adrenal gland of mice and rats (76) , further suggesting that this may not be the pathway responsible for the changes seen in these studies.
In the current study, no significant differences were observed between the WT and CYP7B1KO mice in anxietylike behaviors and CORT secretion. These findings differ from published studies, which demonstrated that systemic or central administration of 3␤-diol reduced anxiety (77) and inhibited CORT release (32, 74) . It is possible that this inconsistency between our current study and those of Figure 6 . Calbindin 28K immunoreactive cell number in the pre optic area of WT and CYP7B1KO mice. Calbindin-ir cell numbers were counted in the Sexually Dimorphic Nucleus of adult male and female WT and CWP7B1KO. Each bar represents the mean ϩ/-SEM of 6 -8 animals. Two-way ANOVA revealed a significant effect of sex (*P Ͻ .05) but not genotype. Lund et al (31, 32) could be due to the following: First, the deletion of CYP7B1 enzyme during development, could have affected the organization of the HPA axis and stress circuitry. Second, while Lund et al (31, 32) studied the acute effects of varied doses of 3␤-diol, our experiments evaluated the long term and chronic effects of CYP7B1 deletion, which could affect the dynamics of 3␤-diol metabolism. Third, it is possible that 3␤-diol levels in the appropriate brain regions responding to stress may not be elevated in the CYP7B1KO. Our initial attempts to measure 3␤-diol in the brain have not been very successful and we are pursuing the measurement using liquid chromatography-mass spectrometry. Finally, the differences observed in the present study could be due to background and species differences. While our study used mice from the C57BL/6J background strain, Lund et al (31, 32) used CBB6/F1 strain of mice and rats.
In concordance with the behavioral observations, HPA axis reactivity was found to be independent of genotype, since no difference was seen in CORT levels between WT and CYP7B1KO mice after exposure to EPM. Furthermore, in both genotypes, T treatment leads to a decrease in CORT levels in response to stress (EPM). While confirming the inhibitory impacts of T on HPA axis reactivity (4), these findings suggest an unimpaired HPA axis in CYP7B1KO mice.
In summary, the results shown here clearly demonstrate a novel role for CYP7B1 in the regulation of male reproductive behaviors. Using transgenic CYP7B1KO male mice treated with T we demonstrate that deletion of CYP7B1 results in defective male reproductive behaviors by a possible impairment in AR-dependent signaling in the olfactory system. Our future studies will determine whether the reproductive defects shown here are sex specific and whether chronic disruption of CYP7B1 enzyme also plays a critical role in females.
